Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design

To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treated at Fudan University...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2017-11, Vol.8 (56), p.95973-95980
Hauptverfasser: Li, Chao, Zhu, Yinju, Tong, Tong, Xu, Ye, Guan, Yun, Wang, Jingwen, Wang, Huankun, Zhu, Ji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 95980
container_issue 56
container_start_page 95973
container_title Oncotarget
container_volume 8
creator Li, Chao
Zhu, Yinju
Tong, Tong
Xu, Ye
Guan, Yun
Wang, Jingwen
Wang, Huankun
Zhu, Ji
description To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treated at Fudan University Shanghai Cancer Center between January 2008 and December 2012. The following were collected depending on availability: operative report, histological report, specimen photographs, initial preoperative images, images confirming local recurrence, and clinical history. A total of 203 lesions of local recurrence were identified. The most common sites of pelvic recurrence were the mesorectum, including the anastomotic stoma in 53.0% of cases; presacral space in 27.4%, and pelvic floor and perineum in 21.4% the cases. Recurrence was most common in the lower pelvic region (i.e., below the upper border of the acetabulum), accounting for approximately 76.2% (128 cases) of cases. In patients with mid-rectal and distal rectal carcinoma. Patients with pelvic cancer may benefit by individualized treatment plans aimed at achieving a balance between tumor control and minimal risk of irradiation-induced toxicity.
doi_str_mv 10.18632/oncotarget.21616
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5707074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29221180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-ecf5efced491deea46e9ca0afa2588139137d6ac28b3851557f74a31a2a520343</originalsourceid><addsrcrecordid>eNpVUdtKAzEQDaJoqX6AL5IfaN0km734IEjxBoI-6PMyZic1km6WJF3o__ihZuutZh6Smck5Z5hDyCnL5qwqBD93nXIR_BLjnLOCFXtkwuq8nnEpxf7O-4ichPCepSPzsuL1ITniNeeMVdmEfDyhHYyiHtXae-wUUtARPW1Rm85EMyAN6yTiN1Q7T61TYO2GQjtA-tyOwAiWqjHzFxRSIXoX-lQesaYbMESzhGhcR52mZtVbo7Zp2DL2icGEseuhNS6-oYc-iRm0bZoimGV3TA402IAn3_eUvNxcPy_uZg-Pt_eLq4eZEpLFGSotUaeh8pq1iJAXWCvIQAOXVcVEzUTZFqB49SoqyaQsdZmDYMBB8kzkYkouv3j79esKW4Vd9GCb3psV-E3jwDT_O515a5ZuaGSZpRgJ2BeBSisIHvUvlmXN1rXmz7Vm61rCnO2K_iJ-PBKfEWedfQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free E- Journals</source><creator>Li, Chao ; Zhu, Yinju ; Tong, Tong ; Xu, Ye ; Guan, Yun ; Wang, Jingwen ; Wang, Huankun ; Zhu, Ji</creator><creatorcontrib>Li, Chao ; Zhu, Yinju ; Tong, Tong ; Xu, Ye ; Guan, Yun ; Wang, Jingwen ; Wang, Huankun ; Zhu, Ji</creatorcontrib><description>To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treated at Fudan University Shanghai Cancer Center between January 2008 and December 2012. The following were collected depending on availability: operative report, histological report, specimen photographs, initial preoperative images, images confirming local recurrence, and clinical history. A total of 203 lesions of local recurrence were identified. The most common sites of pelvic recurrence were the mesorectum, including the anastomotic stoma in 53.0% of cases; presacral space in 27.4%, and pelvic floor and perineum in 21.4% the cases. Recurrence was most common in the lower pelvic region (i.e., below the upper border of the acetabulum), accounting for approximately 76.2% (128 cases) of cases. In patients with mid-rectal and distal rectal carcinoma. Patients with pelvic cancer may benefit by individualized treatment plans aimed at achieving a balance between tumor control and minimal risk of irradiation-induced toxicity.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.21616</identifier><identifier>PMID: 29221180</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>Oncotarget, 2017-11, Vol.8 (56), p.95973-95980</ispartof><rights>Copyright: © 2017 Li et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707074/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707074/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29221180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Chao</creatorcontrib><creatorcontrib>Zhu, Yinju</creatorcontrib><creatorcontrib>Tong, Tong</creatorcontrib><creatorcontrib>Xu, Ye</creatorcontrib><creatorcontrib>Guan, Yun</creatorcontrib><creatorcontrib>Wang, Jingwen</creatorcontrib><creatorcontrib>Wang, Huankun</creatorcontrib><creatorcontrib>Zhu, Ji</creatorcontrib><title>Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treated at Fudan University Shanghai Cancer Center between January 2008 and December 2012. The following were collected depending on availability: operative report, histological report, specimen photographs, initial preoperative images, images confirming local recurrence, and clinical history. A total of 203 lesions of local recurrence were identified. The most common sites of pelvic recurrence were the mesorectum, including the anastomotic stoma in 53.0% of cases; presacral space in 27.4%, and pelvic floor and perineum in 21.4% the cases. Recurrence was most common in the lower pelvic region (i.e., below the upper border of the acetabulum), accounting for approximately 76.2% (128 cases) of cases. In patients with mid-rectal and distal rectal carcinoma. Patients with pelvic cancer may benefit by individualized treatment plans aimed at achieving a balance between tumor control and minimal risk of irradiation-induced toxicity.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVUdtKAzEQDaJoqX6AL5IfaN0km734IEjxBoI-6PMyZic1km6WJF3o__ihZuutZh6Smck5Z5hDyCnL5qwqBD93nXIR_BLjnLOCFXtkwuq8nnEpxf7O-4ichPCepSPzsuL1ITniNeeMVdmEfDyhHYyiHtXae-wUUtARPW1Rm85EMyAN6yTiN1Q7T61TYO2GQjtA-tyOwAiWqjHzFxRSIXoX-lQesaYbMESzhGhcR52mZtVbo7Zp2DL2icGEseuhNS6-oYc-iRm0bZoimGV3TA402IAn3_eUvNxcPy_uZg-Pt_eLq4eZEpLFGSotUaeh8pq1iJAXWCvIQAOXVcVEzUTZFqB49SoqyaQsdZmDYMBB8kzkYkouv3j79esKW4Vd9GCb3psV-E3jwDT_O515a5ZuaGSZpRgJ2BeBSisIHvUvlmXN1rXmz7Vm61rCnO2K_iJ-PBKfEWedfQ</recordid><startdate>20171110</startdate><enddate>20171110</enddate><creator>Li, Chao</creator><creator>Zhu, Yinju</creator><creator>Tong, Tong</creator><creator>Xu, Ye</creator><creator>Guan, Yun</creator><creator>Wang, Jingwen</creator><creator>Wang, Huankun</creator><creator>Zhu, Ji</creator><general>Impact Journals LLC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20171110</creationdate><title>Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design</title><author>Li, Chao ; Zhu, Yinju ; Tong, Tong ; Xu, Ye ; Guan, Yun ; Wang, Jingwen ; Wang, Huankun ; Zhu, Ji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-ecf5efced491deea46e9ca0afa2588139137d6ac28b3851557f74a31a2a520343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Li, Chao</creatorcontrib><creatorcontrib>Zhu, Yinju</creatorcontrib><creatorcontrib>Tong, Tong</creatorcontrib><creatorcontrib>Xu, Ye</creatorcontrib><creatorcontrib>Guan, Yun</creatorcontrib><creatorcontrib>Wang, Jingwen</creatorcontrib><creatorcontrib>Wang, Huankun</creatorcontrib><creatorcontrib>Zhu, Ji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Chao</au><au>Zhu, Yinju</au><au>Tong, Tong</au><au>Xu, Ye</au><au>Guan, Yun</au><au>Wang, Jingwen</au><au>Wang, Huankun</au><au>Zhu, Ji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2017-11-10</date><risdate>2017</risdate><volume>8</volume><issue>56</issue><spage>95973</spage><epage>95980</epage><pages>95973-95980</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treated at Fudan University Shanghai Cancer Center between January 2008 and December 2012. The following were collected depending on availability: operative report, histological report, specimen photographs, initial preoperative images, images confirming local recurrence, and clinical history. A total of 203 lesions of local recurrence were identified. The most common sites of pelvic recurrence were the mesorectum, including the anastomotic stoma in 53.0% of cases; presacral space in 27.4%, and pelvic floor and perineum in 21.4% the cases. Recurrence was most common in the lower pelvic region (i.e., below the upper border of the acetabulum), accounting for approximately 76.2% (128 cases) of cases. In patients with mid-rectal and distal rectal carcinoma. Patients with pelvic cancer may benefit by individualized treatment plans aimed at achieving a balance between tumor control and minimal risk of irradiation-induced toxicity.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>29221180</pmid><doi>10.18632/oncotarget.21616</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2017-11, Vol.8 (56), p.95973-95980
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5707074
source PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free E- Journals
subjects Research Paper
title Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T07%3A07%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pelvic%20recurrence%20after%20definitive%20surgery%20for%20locally%20advanced%20rectal%20cancer:%20a%20retrospective%20investigation%20of%20implications%20for%20precision%20radiotherapy%20field%20design&rft.jtitle=Oncotarget&rft.au=Li,%20Chao&rft.date=2017-11-10&rft.volume=8&rft.issue=56&rft.spage=95973&rft.epage=95980&rft.pages=95973-95980&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.21616&rft_dat=%3Cpubmed_cross%3E29221180%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29221180&rfr_iscdi=true